Stockscreener 앱 받기
153.05
2.58%
-4.06
시간 외 거래:
153.05
Charles River Laboratories International Inc 주식(CRL)의 최신 뉴스
Charles River Laboratories International Inc. stock outperforms competitors on strong trading day - MarketWatch
FDA issues guidance on replacing animal testing (CRL:NYSE) - Seeking Alpha
Charles River Laboratories International, Inc. (NYSE:CRL) Sees Significant Increase in Short Interest - MarketBeat
Charles River Laboratories International Inc. stock underperforms Tuesday when compared to competitors despite daily gains - MarketWatch
Charles River Laboratories International Inc. stock underperforms Thursday when compared to competitors - MSN
Charles River Laboratories International (CRL) faces biotech R&D spending headwinds - MSN
National Bank of Canada FI Grows Stock Position in Charles River Laboratories International, Inc. $CRL - MarketBeat
Charles River announces divestitures, updates guidance - MSN
Charles River Laboratories International Inc. stock underperforms Monday when compared to competitors - MarketWatch
CRL,PBE Volatility & Greeks - Finviz
Charles River Laboratories International, Inc. $CRL Holdings Reduced by Iron Triangle Partners LP - MarketBeat
Gotham Asset Management LLC Acquires 46,594 Shares of Charles River Laboratories International, Inc. $CRL - MarketBeat
Charles River Laboratories International, Inc. Common Stock (NY: CRL - The Chronicle-Journal
Charles River Laboratories Hits Day Low of $151.91 Amid Price Pressure - Markets Mojo
Earnest Partners LLC Raises Holdings in Charles River Laboratories International, Inc. $CRL - MarketBeat
Algert Global LLC Buys 39,586 Shares of Charles River Laboratories International, Inc. $CRL - MarketBeat
Charles River Laboratories Stock (ISIN: US1591881009) Surges on Earnings Beat and $1B Buyback Amid R - AD HOC NEWS
A Look At Charles River Laboratories (CRL) Valuation After Its Earnings Beat And New US$1b Buyback - simplywall.st
Are Charles River’s New Advanced Therapy Deals Quietly Rewriting Its Drug-Development Moat Story (CRL)? - Sahm
Charles River announces strategic review including 'examination of various alternatives' - MSN
Charles River Laboratories International, Inc. $CRL Position Lessened by Integral Health Asset Management LLC - MarketBeat
Charles River Laboratories International, Inc. (NYSE:CRL) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
Meridiem Capital Partners LP Sells 49,567 Shares of Charles River Laboratories International, Inc. $CRL - MarketBeat
Zacks Research Issues Negative Outlook for CRL Earnings - MarketBeat
Connor Clark & Lunn Investment Management Ltd. Has $28.25 Million Stock Holdings in Charles River Laboratories International, Inc. $CRL - MarketBeat
Charles River Laboratories (CRL) slides 9.6% as investors refocus on restructuring, mixed 2026 outlook, and overhang risks - Quiver Quantitative
Charles River Labs Stock: Strong Performance vs. Underlying Business ChallengesNews and Statistics - IndexBox
Zacks Research Has Optimistic Outlook of CRL Q2 Earnings - MarketBeat
Mackenzie Financial Corp Decreases Stock Holdings in Charles River Laboratories International, Inc. $CRL - MarketBeat
Charles River Laboratories International, Inc. $CRL Stock Position Lifted by Magnetar Financial LLC - MarketBeat
Natixis Advisors LLC Acquires 20,050 Shares of Charles River Laboratories International, Inc. $CRL - MarketBeat
Barclays PLC Reduces Holdings in Charles River Laboratories International, Inc. $CRL - MarketBeat
Locus Cell, Taiwan-Based Cell and Gene Therapy CDMO, Signs MoU with Charles River at APAC Biomanufacturing Leadership Summit - Morningstar
Charles River Laboratories International Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
[Latest] Global Pharmaceutical Microbiology QC Testing Market Size/Share Worth USD 17.65 Billion by 2035 at a 13.27% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, SWOT Analysis) - GlobeNewswire Inc.
CRL: Biotech demand is recovering, tech investments continue, and acquisitions strengthen core focus - TradingView
CRL: Biotech demand rebounds, portfolio streamlined, and China’s innovation eyed for future growth - TradingView
Charles River Laboratories International (CRL) Gains on Strong Results and Resilient Drug Outsourcing Demand - Insider Monkey
A Look At Charles River Laboratories (CRL) Valuation After 2026 Guidance Cut And Planned Divestitures - Yahoo Finance
Dimensional Fund Advisors LP Purchases 120,207 Shares of Charles River Laboratories International, Inc. $CRL - MarketBeat
How Investors Are Reacting To Charles River Laboratories (CRL) Cutting 2026 Guidance After Planned Divestitures - Yahoo Finance
GW&K Investment Management LLC Increases Position in Charles River Laboratories International, Inc. $CRL - MarketBeat
Why Charles River Laboratories International Inc. stock is upgraded to buy2025 Sector Review & AI Enhanced Trading Alerts - Naître et grandir
Quantbot Technologies LP Invests $1.44 Million in Charles River Laboratories International, Inc. $CRL - MarketBeat
Baird maintains outperform rating on Charles River Laboratories International, Inc. (CRL) - MSN
Charles River Laboratories International (CRL) Faces Biotech R&D Spending Headwinds - Insider Monkey
Picton Mahoney Asset Management Boosts Stock Holdings in Charles River Laboratories International, Inc. $CRL - MarketBeat
LaPlume buys Charles River Labs [CRL] shares worth $4363 - Investing.com India
0.55%
2.50%
자본화:
|
볼륨(24시간):